Waters Corporation (NYSE: WAT) Reports Third Quarter 2024 Financial Results

Highlights Sales of $740 million exceeded guidance, grew 4% as reported and 4% in constant currency Instruments returned to growth; recurring revenue grew high single-digits in constant currency All reported regions returned to growth in the quarter; sales grew across all end markets, led by Pharma & Industrial GAAP EPS of$ 2.71 and non-GAAP EPS of $2.93 significantly exceeded guidance, led by strong operational performance and better-than-expected market conditions Raised full-year sales and EPS guidance, ...